title: Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine.
abstract: OBJECTIVE
  Recombinant subunit vaccines provide safe and targeted protection against microbial infections. However, the protective efficacy of recombinant subunit vaccines tends to be less potent than the whole cell vaccines, especially when they are administered through mucosal routes. We have reported that a bacterial flagellin has strong mucosal adjuvant activity to induce protective immune responses. In this study, we tested whether FlaB could be used as a fusion partner of subunit vaccine for tetanus.
  
  
  METHODS
  We constructed fusion proteins consisted with tetanus toxin fragment C (TTFC), the nontoxic C-terminal portion of tetanus toxin, and a Toll-like receptor 5 agonist from Vibrio vulnificus (FlaB). Mice were intranasally administered with fusion protein and protective immune responses of the vaccinated mice were analyzed.
  
  
  RESULTS
  FlaB-TTFC recombinant protein induced strong tetanus-specific antibody responses in both systemic and mucosal compartments and prolonged the survival of mice after challenge with a supra-lethal dose of tetanus toxin.
  
  
  CONCLUSIONS
  This study establishes FlaB as a successful fusion partner for recombinant subunit tetanus vaccine applicable through mucosal route, and it further endorses our previous observations that FlaB could be a stable adjuvant partner for mucosal vaccines.
authors: Clinical Vaccine R&D Center, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. ; Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, Korea.
authors: Shee Eun
authors: 0000-0002-2023-3317
authors: SE
authors: Lee
authors: Clinical Vaccine R&D Center, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. ; Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea.
authors: Chung Truong
authors: 0000-0001-9881-0295
authors: CT
authors: Nguyen
authors: Clinical Vaccine R&D Center, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. ; Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea.
authors: Soo Young
authors: 0000-0002-6304-0689
authors: SY
authors: Kim
authors: Clinical Vaccine R&D Center, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. ; Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea.
authors: Thinh Nguyen
authors: 0000-0002-4874-3458
authors: TN
authors: Thi
authors: Clinical Vaccine R&D Center, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. ; Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea.
authors: Joon Haeng
authors: 0000-0003-4018-3203
authors: JH
authors: Rhee
keywords: Adjuvant; Flagellin; Subunit vaccine; Tetanus toxin fragment C
references: J Immunol. 1952 Sep;69(3):273-83
references: 13000137
references: Nat Protoc. 2009;4(3):363-71
references: 19247286
references: Vaccine. 2012 Jan 5;30(2):466-74
references: 22051136
references: J Biotechnol. 2014 Apr 10;175:31-7
references: 24530504
references: Clin Exp Vaccine Res. 2012 Jul;1(1):50-63
references: 23596577
references: Vaccine. 1995 Apr;13(5):463-70
references: 7543714
references: PLoS One. 2010 Nov 05;5(11):e13849
references: 21079762
references: Infect Immun. 2014 Jan;82(1):29-42
references: 24101693
references: Curr Opin Immunol. 2012 Jun;24(3):337-42
references: 22541723
references: Curr Top Med Chem. 2013;13(20):2562-80
references: 24066891
references: Br J Anaesth. 2001 Sep;87(3):477-87
references: 11517134
references: Nature. 2001 Apr 26;410(6832):1099-103
references: 11323673
references: Mol Biotechnol. 2014 May;56(5):394-407
references: 24271565
references: Front Immunol. 2013 Dec 02;4:407
references: 24348475
references: Vaccine. 1997 Apr-May;15(6-7):616-9
references: 9178460
references: Nucleic Acids Res. 1989 Dec 25;17(24):10191-202
references: 2690015
references: Biotechnol Appl Biochem. 2000 Apr;31 ( Pt 2):91-4
references: 10744952
references: Vaccine. 2010 Aug 31;28 Suppl 3:C25-36
references: 20713254
references: Vaccine. 2011 Jun 24;29(29-30):4778-84
references: 21565244
references: Infect Immun. 2006 Jan;74(1):694-702
references: 16369026
references: Infect Immun. 2004 Oct;72(10):5931-7
references: 15385496
references: J Parasitol Res. 2011;2011:965369
references: 21603205
references: ChemMedChem. 2013 Mar;8(3):360-76
references: 23316023
references: J Control Release. 2014 Mar 28;178:1-7
references: 24417966
references: Vaccine. 2011 Aug 5;29(34):5731-9
references: 21696869
references: Nat Immunol. 2003 Dec;4(12):1247-53
references: 14625549
references: Ther Deliv. 2011 Aug;2(8):1057-77
references: 22826868
references: Hum Vaccin. 2007 Sep-Oct;3(5):205-11
references: 17881903
references: Science. 1989 Oct 27;246(4929):497-500
references: 2683073
references: Front Immunol. 2014 Apr 23;5:188
references: 24795730
references: Nat Immunol. 2006 Aug;7(8):868-74
references: 16829963
references: Nat Med. 2013 Dec;19(12):1597-608
references: 24309663
references: Nat Rev Microbiol. 2011 Oct 03;9(12 ):889-93
references: 21963800
references: Curr Opin Pulm Med. 2014 May;20(3):294-300
references: 24626237
references: Microbiol Immunol. 2012 Sep;56(9):595-604
references: 22708880